Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review. Bukhari S, Khan SZ, Bashir Z. J Card Fail 2023;29:76-86.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bukhari S, Khan SZ, Bashir Z. Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review. J Card Fail 2023;29:76-86.
PMID: 36122817